Real-World Efficacy and Safety of Nivolumab in Previously-Treated Metastatic Renal Cell Carcinoma, and Association Between Immune-Related Adverse Events and Survival: The Italian Expanded Access Program
Journal for ImmunoTherapy of Cancer - United Kingdom
doi 10.1186/s40425-019-0579-z
Full Text
Open PDFAbstract
Available in full text
Date
April 3, 2019
Authors
Publisher
BMJ